Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Nov 27, 2026; 18(11): 124030
Published online Nov 27, 2026. doi: 10.4240/wjgs.124030
Published online Nov 27, 2026. doi: 10.4240/wjgs.124030
Table 5 Univariate analysis of acute kidney injury after hepatocellular carcinoma ablation
| Indicators | B | SE | Wald | P value | OR | 95%CI |
| Age (years) | 1.016 | 0.451 | 5.085 | 0.024 | 2.762 | 1.142-6.679 |
| Comorbid diabetes | 1.043 | 0.451 | 5.349 | 0.021 | 2.839 | 1.172-6.873 |
| TNM staging | 0.951 | 0.487 | 3.807 | 0.051 | 2.588 | 0.996-6.728 |
| Tumor length (cm) | 0.326 | 0.125 | 6.859 | 0.009 | 1.386 | 1.086-1.769 |
| Hemoglobin (g/L) | -0.105 | 0.021 | 24.717 | < 0.001 | 0.900 | 0.864-0.938 |
| Uric acid (μmol/L) | 0.005 | 0.002 | 4.616 | 0.032 | 1.005 | 1.000-1.010 |
| Creatinine (μmol/L) | 0.044 | 0.013 | 12.228 | < 0.001 | 1.045 | 1.020-1.072 |
- Citation: Luo DW, Du HL, Duan WX. Acute kidney injury after liver cancer ablation: Risk factors and perioperative management. World J Gastrointest Surg 2026; 18(11): 124030
- URL: https://www.wjgnet.com/1948-9366/full/v18/i11/124030.htm
- DOI: https://dx.doi.org/10.4240/wjgs.124030